Pharmaceuticals Japan

Japan Sedation Drugs Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Japan Sedation Drugs Market Industry Trends and Forecast to 2034: Segmented by (Drug, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Japan · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $205.7 Mn Placeholder estimate
Estimate 2025 $216.9 Mn 6.6% of the global market
Projected 2034 $348.1 Mn 60.5% Adds $131.3 Mn over 9 forecast years
CAGR 2025–2034 5.4% Faster than 15% of 180 Pharmaceuticals markets here
Key players 5
  • Japan is 6.56% of the global market.
  • In APAC, the largest is China at $303.4 Mn.
  • Fastest growing: India at 7.9% a year.
  • Japan ranks 2nd of 10 by size in APAC.

Market size projection

Japan

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$131.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Sedation Drugs Market market size by year, Japan
YearMarket sizeChange that yearSince 2025
2024 (estimate) $205.7 Mn — —
2025 (base) $216.9 Mn +$11.1 Mn —
2026 (forecast) $228.6 Mn +$11.7 Mn +5.4%
2027 (forecast) $240.9 Mn +$12.3 Mn +11.1%
2028 (forecast) $253.9 Mn +$13.0 Mn +17.1%
2029 (forecast) $267.6 Mn +$13.7 Mn +23.4%
2030 (forecast) $282.1 Mn +$14.5 Mn +30.1%
2031 (forecast) $297.3 Mn +$15.2 Mn +37.1%
2032 (forecast) $313.4 Mn +$16.1 Mn +44.5%
2033 (forecast) $330.3 Mn +$16.9 Mn +52.3%
2034 (forecast) $348.1 Mn +$17.8 Mn +60.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Japan Sedation Drugs Market Analysis at a glance
Market size, 2025$216.9 Mn placeholder estimate
Forecast, 2034$348.1 Mn placeholder estimate
Growth (CAGR), 2025–20345.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledSedative-Hypnotic Drugs
SegmentsDrug, setting and end user (see all)
Key playersFresenius Kabi AG, Pfizer Inc., Hikma Pharmaceuticals PLC, Acacia Pharma (Eagle), Baxter International (see all)
Regulator in JapanPMDASource: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Japan Sedation Drugs Market Analysis Executive Summary

Sedation drugs calm patients during procedures and in intensive care, such as propofol, dexmedetomidine and midazolam.

Key segments of the sedation Drugs market include drug (Propofol, Dexmedetomidine and Midazolam) and setting (ICU, Procedural Sedation and Surgery).

Bar chart: Japan Sedation Drugs market size, 2024–2034, placeholder estimates. $205.7 Mn in 2024, $216.9 Mn in 2025 and $348.1 Mn in 2034, 5.4% CAGR.
Japan Sedation Drugs market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Japan Sedation Drugs Market Dynamics

Market Growth Drivers

More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the sedation Drugs market.

Opportunity

Ready-to-use formulations, biosimilars and supply security programmes give the sedation Drugs market room to grow.

Market Restraints

Drug shortages, price controls, generic competition and strict hospital budgets hold back the sedation Drugs market.

Competitive Landscape for Sedation Drugs Market in Japan

The sedation Drugs market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Sedation Drugs Market in Japan

Sedation Drugs in Japan: rules and payment

Drugs are reviewed by the Pharmaceuticals and Medical Devices Agency (PMDA) and approved by the Ministry of Health, Labour and Welfare (MHLW).⁠[1] Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices).⁠[2]

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for sedation Drugs. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Japan.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Sedation Drugs right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Sedation Drugs in context

Japan compared

  • Health spending per person: 3,638 US$ per person (2023). World: 1,317 US$ per person (2023). 4th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.65 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 5th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 30.0% of people (2025). World: 10.4% of people (2025). Highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.

Free data on this topic

Inside Japan

Quick answers

Frequently asked questions

How big is the Sedation Drugs market in Japan?
Placeholder estimate: about $216.9 Mn in 2025, rising to about $348.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Sedation Drugs market in Japan growing?
Placeholder estimate: about 5.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Sedation Drugs market report cover?
The report splits the market by drug (Propofol, Dexmedetomidine, Midazolam, Remimazolam), setting (ICU, Procedural Sedation, Surgery) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Sedation Drugs market?
Key players include Fresenius Kabi AG, Pfizer Inc., Hikma Pharmaceuticals PLC, Acacia Pharma (Eagle) and Baxter International.
What is driving the Sedation Drugs market?
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the sedation Drugs market.
Who regulates Sedation Drugs in Japan?
Drugs are reviewed by the Pharmaceuticals and Medical Devices Agency (PMDA) and approved by the Ministry of Health, Labour and Welfare (MHLW). Source: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
How is healthcare paid for in Japan?
Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices). Source: Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
How much research is published on Sedation Drugs?
PubMed lists 19 papers on Sedation Drugs added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Japan

See all

Related on hospital and surgery

See the topic